Daily news email for March 06, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
Medicyte and PRIMACYT Receive Grant to Develop Human Liver Cells for Cell-based Therapies

Annual Report on Celera (Quest) License

Haselmeier Establishes New Pen Injector Assembly Facility in India

Medicyte Now with Online Shop for Upcyte® Hepatocytes and Innovative Cell Products

Genervon to Award Price for Scientists Proposing Medical Indications and Trial Protocols - ...

BioSpace
Shire plc to Initiate Two Phase 4 Clinical Trials to Compare Vyvanse (lisdexamfetamine dimesylate) Capsules, (CII) to Concerta (methylphenidate HCl) Extended-Release Tablets, (CII)

Ranbaxy Laboratories Launches Generic Atorvastatin in European Markets

Younger Children in the Classroom Likely Overdiagnosed With ADHD, University of British Columbia Study

Jazz Pharmaceuticals, Inc. Falls on Offering of 7.88 Million Shares

Former FDA Chemist Gets 5 Years for Insider Trading

BioSpace - Breaking News
Cytokinetics, Inc. Announces That the European Medicines Evaluation Agency Has Granted CK-2017357 Orphan Medicinal Product Designation for the Treatment of Amyotrophic Lateral Sclerosis

Millennium: The Takeda Oncology Company Initiates Pivotal Phase 3 Trial of MLN8237 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Derma Sciences, Inc. Meeting with FDA Supports Initiation of Phase 3 Studies with DSC127 in Diabetic Foot Ulcers

Merck KGaA Forecasts Higher Revenue, Profit Hurt by Costs

As Keryx Biopharmaceuticals, AEterna Zentaris Shares Surge, Investing Writer's Credibility Questioned

Biotech News - Business Wire
Lab21 and ITOR launch Clinical Genomics Center in USA

MyBioID Personal Recognition Service Supports OpenID Authentication Protocols

Research and Markets: Biotechnology - Global Outlook

Quotient Biodiagnostics Raises $11.2 Million of Growth Finance Led by Galen Partners

Nuvilex Forecasts Vast Partnership Opportunities Using Breakthrough Stem Cell Technology

Biotech News - PR Newswire
PharmAthene to Host Year-End 2011 Earnings Conference Call and Webcast on Thursday, March 8, 2012

Sysmex America Prepares for Accelerated Growth

Unternehmen von Berg Pharma präsentieren bahnbrechenden Ansatz zum Verständnis von Autismus und identifizieren neuartige Biomarker, die eine entscheidende Rolle bei der Diagnose spielen könnten

DERMALOG en la CeBIT 2012: Inicio de sesión con huellas dactilares - Deshaciéndose de nombres de usuario y contraseñas

Las compañías Berg Pharma presentan un enfoque pionero para entender el autismo e identificar nuevos biomarcadores que podrían resultar cruciales en el diagnóstico

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
Joint Custody

Bribery a Growing Legal Liability for Big Pharma, says Reuters

Galapagos Scores with Abbott Deal

Shire Inks Antibody Discovery Alliance with arGEN-X

NIH Takes Its Genetic Testing Registry Online

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Safety Huber Needles

Ivantis Enrolls First Patient for U.S. Clinical Study on Glaucoma

PSI Announces Revenue and Client Growth for 2011

Research and Markets: Colorectal Cancer Global Clinical Trials Review, H2, 2011

Research and Markets: Meningitis Global Clinical Trials Review, H2, 2011

Clinical Trials - PR Newswire
Unlocking Autism's Mysteries: CMU's Marcel Just Uses New Brain Imaging and Computer Modeling to Predict Autistic Brain Activity and Behavior

InspireMD Announces its 2011 Year End Financial Results

Kids' Abnormal Breathing During Sleep Linked to Increased Risk For Behavioral Difficulties

ECLINSO Announces Partnership with XClinical

Ankle Replacement Rapidly on the Rise

CNN Top Stories
LulzSec hackers arrested, source says

U.S., other nations agree to nuclear talks with Iran

Sales of Cuban cigars on the rise

Death toll doubles in Yemen 'slaughter'

Syria activists: Escape route attacked

Contract Pharma
EntreMed To Open China Office, Ends SVT Alliance

Absorption Systems Awarded Third CellPort Patent

AmerisourceBergen To Acquire World Courier

Abbott, Merck In Companion Diagnostic Pact

Novella Clinical Appoints Executive

FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Cambios importantes en la etiqueta de seguridad de los medicamentos para reducir el colesterol conocidos como estatinas

FDA Drug Safety Communication: Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury

FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs

CDER World

Comunicado de la FDA sobre la seguridad de los medicamentos: Reingreso planeado al mercado de CardioGen-82 con nuevo recuadro de advertencia

FDA News - Business Wire
Derma Sciences Meeting with FDA Supports Initiation of Phase 3 Studies with DSC127 in Diabetic Foot Ulcers

FDA Accepts Resubmission of Perampanel New Drug Application

Cannabis Science Targets Opportune Immediate European Expansion With Acquisitions & Licensing Deals; Negotiations For First European Deal Is In Final Stages For New Products, Revenues, and Management

CORRECTING and REPLACING Repligen Announces Submission of Marketing Authorization Application in EU for SecreFlo to Improve Pancreatic Imaging in Patients with Pancreatitis

UE LifeSciences Inc. Announces FDA Clearance for Complementary Breast Cancer Screening Device

FDA Press Releases
La FDA anuncia modificaciones relacionadas con la seguridad en las indicaciones de algunos medicamentos que reducen el colesterol

FDA approves two new pancreatic enzyme products to aid food digestion

FDA approves first quadrivalent vaccine to prevent seasonal influenza

FDA reaches $1 million settlement with Pennsylvania medical device firm

FDA announces safety changes in labeling for some cholesterol-lowering drugs

FDA Vaccines, Blood and Biologics - What's New
Cord Blood Banking Information for Consumers

Cord Blood Banking – Information for Consumers

Cord Blood Banking ââ¬â Information for Consumers

Influenza Virus Vaccine for the 2011 - 2012 Season

Fluzone, Fluzone High-Dose and Fluzone Intradermal

FierceBiotech
Oncothyreon shares routed as Stimuvax PhIII trial soldiers on

Domain partners with RusNano on $760M biotech investment plan

Aragon raises $42M for closely-watched prostate cancer drug

Company 'insiders' left with 43% of Verastem's shares

PhIII placebo response complicates Lundbeck's case for anti-drinking drug

FierceBiotech IT
Ex-NCI cancer informatics chief lands at ASU

FDA calls out Biochem for IT no-nos

Reuters advances life sciences informatics platform

Social media jump-starts stalled patient recruitment efforts

NIH backs effort to integrate clinical trials data into EHRs

FierceBiotech Research
Beefed-up FAK protein slashed heart attack damage in mice

UPDATED: UCLA's 'molecular tweezers' dismantles Parkinson's in zebra fish

Breakthrough IDs possible liver repair process

The battle to halt Alzheimer's may come down to sugar

UPDATED: UCLA's 'molecular tweezers' dismantles Parkinson's in zebrafish

FiercePharma
HHS: Misbehaving drugmakers could lose patent rights

More reps sue Novo for back overtime

Chinese official chides hospitals for high drug prices

Merck's new cholesterol combo faces delay

How worrisome is the statin-diabetes link

FiercePharma Manufacturing
FDA cites Gulf Pharmaceutical for predating documentation

GlaxoSmithKline, Daiichi Sankyo join forces to sell vaccines in Japan

Boehringer Ingelheim spends 17M on expansion in Germany, Vienna

AmerisourceBergen buys another pharmaceutical services company

India's Emcure to manufacture Roche's Herceptin, MabThera

FierceVaccines
UPDATED: Getting under the skin of vaccines

AstraZeneca's FluMist Quadrivalent to hit U.S. market

Getting under the skin of vaccines

Inactivated polio vaccine reaches Nigeria

Bacteria may lead to HIV vaccine

Health News - BizJournals.com
Group: Brain injuries costly to more than individuals

MIT, Dana-Farber launch joint cancer research funding program

Children's Medical in Plano lands $1M donation

Univita Health buys All-Med Services and its 800 workers

Schwartz Center gets $500K Amgen grant

Health News - CNBC
Dendreon CEO on Prescription Challenges

AmerisourceBergen to buy World Courier for $520M

Germany's Merck KGaA increases Q4 net to $179M

Lasting symptoms possible after kids' concussions: study

Jazz Pharma shareholders selling 7.9M shares

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
4s3 Raises $20M to Create Protein Therapies for Orphan Neuromuscular Disorders

Dr. Guttman, Invited Expert Panelist for America Invents Act Webinar Entitled "What Biomedical Companies & Entrepreneurs Need to Know"

Fast Forward to Provide Funding for Concert's MS Spasticity and Pain Candidate

Vascular Magnetics Raises $7M to Develop Magnetically Targeted Nanoparticles for PAD

Biotech Leaders Oppose Washington State Plan to Cut Tax Credit to Aid High-Tech Education

Marketwire - Pharma and Biotech
ProMetic Secures a $2.5 Million Follow on Agreement

Lpath Raises $9.3 Million in Equity Financing

Pacgen Appoints Peter Sheu as COO

ProMetic obtient une nouvelle entente de 2,5 millions $

Proteonomix Announces a Private Placement of $3.8 Million

MassBio News
MassBio Launches New Blog: MassBioHQ

What has made Massachusetts a better place for biotech Make your nomination by 5 PM on Feb. 24th!

What has made Massachusetts a better place for biotech Make your nomination by Feb. 24th!

MassBio's Peter Abair discusses growth in the cluster with US Building Digest

MassBio Purchasing Consortium Augments Four Major Agreements

Medical Pharma - PR Newswire
UMF Medical Announces New Name

BayScribe Selects Health Fidelity's Natural Language Processing (NLP) Platform to Drive the Application of Unstructured Clinical Data

Ethicon Endo-Surgery Brings Hands-On Lab Training Experience to Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Conference

Dr. Maria M. LoTempio Receives Award From the American Society for Reconstructive Microsurgery

TOUS se suma a (RED) para ayudar a alcanzar una generación libre de sida para el año 2015

National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

Nature Biotechnology
OpenVigilfree eyeballs on AERS pharmacovigilance data

The blinded buyer

Planning for the exit

PRIDE Inspector: a tool to visualize and validate MS proteomics data

2011Big biotechs gorge on debt

New York Times- Biotechnology
Cancer Center, in Suit, Claims Ex-Official Took Research

Life Sciences Development Rebounds in Central New Jersey

Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge

Drew Endy: Better Computing for the Things We Care About Most

New York Times- Pharmaceuticals
India’s Supreme Court to Hear Dispute on Drug Patents

F.D.A. Rejects Merck’s Application for Combination Drug

WELL; The Consumer: A Cocktail Of Drugs May Cloud The Brain

F.D.A Rejects Merck’s Application for Combination Drug

The Diabetes Dilemma for Statin Users

OnBioVC
Aria Diagnostics, Inc.: Series C $52.7M

Avinger, Inc.: Series C $22.5M

RaNA Therapeutics, Inc.: Series A $20.7M

BerGenBio, AS: Series A $8.8M

Prosensa Therapeutics, BV: Series A $30.7M

Outsourcing-Pharma
Social network sites is key to trial recruitment success, says expert

Social network sites key to trial recruitment success, says expert

An experienced CMO is key to successful biologics development says Cobra Biologics

Parexel discusses transdermal drug delivery techs

Sponsors and CROs differ on perception of service quality, says the Avoca Group

Pharma News - Business Wire
Data from Phase 2 Study of an INCIVEK® Combination Regimen Showed 74% of People Co-Infected with Hepatitis C and HIV Had Undetectable Hepatitis C Virus 12 Weeks After Treatment Ended (SVR12)

LEO Pharma Inc. Debuts Patient Assistance Program for Plaque Psoriasis Patients

World Diabetes Therapeutics Market Analyzed in New In-demand Report Published at MarketPublishers.com

Bristol-Myers Squibb to Present at Barclays Capital 2012 Global Health Care Conference

Medgenics Announces 2011 Financial Results

Pharma News - PharmiWeb
Global Overview of the Laboratory and POC Hemostasis Diagostic Market: Facilities, Test Volumes, Sales Forecasts, and Leading Supplier's Sales and Market Shares

Case for Individual Health Insurance Mandate Is a Morton's Fork, Doctor Writes

Pharmaceutical regulatory affairs specialist ELC Group opens new office in Mumbai

BioCity Scotland joins forces with Harrison Goddard Foote

Independent tests confirm that DuPont Tyvek® protective clothing provides excellent permeation resistance to chemicals

Pharma News - PR Newswire
Jon Shirazi Calls for CHILDREN'S CHARITY as New Pediatric Drugs are Rushed to Market

EyeScience® Announces New Product Launch of Diabetic Vision Formula

Biovista Awarded Research Grant on Chronic Fatigue Syndrome From the CFIDS Association of America

EHE International Joins Forces With Entertainment Industry Foundation's National Colorectal Cancer Research Alliance and the CDC to Encourage Screening

Schwartz Center Receives $500,000 Grant from the Amgen Foundation

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

Ascent Scientific licenses novel clathrin inhibitors from Freie Universität Berlin, University of Newcastle and Children's Medical Research Institute

PRWeb - Biotechnology
Glycos Biotechnologies Announces Durable Trends in Renewable Chemicals

Banetti and SRO Solutions Team Up to Deliver Maximo Replication and...

Absorption Systems Awarded Third U.S. Patent for CellPort...

Boehringer Laboratories, LLC. Announces an Assessment Program to Help...

New IonBench LC Provides Safe Operation and Easy Transport of...

PRWeb - Pharmaceuticals
Trinity Consultants Hires Top Arkansas Environmental Expert

Intrinsic Imaging Implements ISPE GAMP 5: A Risk-Based Approach to...

Rottenstein Law Group Applauds FDA Device Chief's Recommendation To...

The Camp Recovery Center to Add Acupuncture to Complement Drug Rehab...

Model N Life Sciences Revenue Management Suite Adds Powerful New...

Scientific American
Raise It or Raze It: How Will the Stranded Italian Cruise Ship Be Salvaged

Could a Penny Dropped Off a Skyscraper Actually Kill You

Industrial Chemicals Linked to Attention Problems in Children

Nine Flying Robots Play 007 Theme

Japan's Post-Fukushima Earthquake Health Woes Go Beyond Radiation Effects

Sports - ESPN Basketball
Three freshmen, big men lead Wooden finalists

Syracuse heads 2013 Maui Invitational field

Coles retires after 16 seasons at Miami (Ohio)

Saint Mary's tops Gonzaga in OT for NCAA bid

Davidson outlasts W. Carolina in double OT

Sports News - ESPN
USC says FB/LB Vehikite is no longer on team

Sandusky lawyers granted access to some info

Penn St. cops: Someone took Paternoville sign

Sandusky's lawyer seeks details of allegations

Syracuse WR Sales reinstated after season ban

Xconomy Life Sciences
San Diego's Aragon Raises $42 Million, Targets Hormone-Driven Cancers

Connect Bestows Hall of Fame Award on Hybritech Founder Ted Greene

Five Reasons Illumina Should Fight Roche's Insulting Low-Ball Bid

Connect and Xconomy Present: The Rock Stars of Innovation 1 Stop Tour

CytomX Therapeutics Seeks to One-Up Lilly, Amgen Cancer Drugs

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)